下咽頭がん治療の世界市場（～2026年）

• 英文タイトル：Global Hypopharyngeal Cancer Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12289
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は下咽頭がん治療のグローバル市場について調査・分析したレポートです。種類別（ガネテスピブ、PGV-001、ニモツズマブ、CDX-3379、その他）市場規模、用途別（外来患者、入院患者）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別下咽頭がん治療の競争状況、市場シェア
・世界の下咽頭がん治療市場：種類別市場規模 2015年-2020年（ガネテスピブ、PGV-001、ニモツズマブ、CDX-3379、その他）
・世界の下咽頭がん治療市場：種類別市場規模予測 2021年-2026年（ガネテスピブ、PGV-001、ニモツズマブ、CDX-3379、その他）
・世界の下咽頭がん治療市場：用途別市場規模 2015年-2020年（外来患者、入院患者）
・世界の下咽頭がん治療市場：用途別市場規模予測 2021年-2026年（外来患者、入院患者）
・北米の下咽頭がん治療市場分析：米国、カナダ
・ヨーロッパの下咽頭がん治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの下咽頭がん治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の下咽頭がん治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの下咽頭がん治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Celldex Therapeutics Inc、Incyte Corp、Madrigal Pharmaceuticals Inc.、Merck & Co Inc
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Hypopharyngeal Cancer Treatment Market
The global Hypopharyngeal Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Hypopharyngeal Cancer Treatment Scope and Market Size
Hypopharyngeal Cancer Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hypopharyngeal Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Celldex Therapeutics Inc
Incyte Corp
Madrigal Pharmaceuticals Inc.
Merck & Co Inc
…

Market segment by Type, the product can be split into
Ganetespib
PGV-001
Nimotuzumab
CDX-3379
Others
Market segment by Application, split into
Out-Patient
In-Patient

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hypopharyngeal Cancer Treatment Revenue
1.4 Market by Type
1.4.1 Global Hypopharyngeal Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ganetespib
1.4.3 PGV-001
1.4.4 Nimotuzumab
1.4.5 CDX-3379
1.4.6 Others
1.5 Market by Application
1.5.1 Global Hypopharyngeal Cancer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Out-Patient
1.5.3 In-Patient
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Hypopharyngeal Cancer Treatment Market Perspective (2015-2026)
2.2 Global Hypopharyngeal Cancer Treatment Growth Trends by Regions
2.2.1 Hypopharyngeal Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hypopharyngeal Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Hypopharyngeal Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hypopharyngeal Cancer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Hypopharyngeal Cancer Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Hypopharyngeal Cancer Treatment Players by Market Size
3.1.1 Global Top Hypopharyngeal Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Hypopharyngeal Cancer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Hypopharyngeal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hypopharyngeal Cancer Treatment Market Concentration Ratio
3.2.1 Global Hypopharyngeal Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hypopharyngeal Cancer Treatment Revenue in 2019
3.3 Hypopharyngeal Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Hypopharyngeal Cancer Treatment Product Solution and Service
3.5 Date of Enter into Hypopharyngeal Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hypopharyngeal Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hypopharyngeal Cancer Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Hypopharyngeal Cancer Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Hypopharyngeal Cancer Treatment Market Size (2015-2020)
6.2 Hypopharyngeal Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Hypopharyngeal Cancer Treatment Market Size (2015-2020)
7.2 Hypopharyngeal Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020)

8 China
8.1 China Hypopharyngeal Cancer Treatment Market Size (2015-2020)
8.2 Hypopharyngeal Cancer Treatment Key Players in China (2019-2020)
8.3 China Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020)
8.4 China Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Hypopharyngeal Cancer Treatment Market Size (2015-2020)
9.2 Hypopharyngeal Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Hypopharyngeal Cancer Treatment Market Size (2015-2020)
10.2 Hypopharyngeal Cancer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020)

11 India
11.1 India Hypopharyngeal Cancer Treatment Market Size (2015-2020)
11.2 Hypopharyngeal Cancer Treatment Key Players in India (2019-2020)
11.3 India Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020)
11.4 India Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Hypopharyngeal Cancer Treatment Market Size (2015-2020)
12.2 Hypopharyngeal Cancer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Celldex Therapeutics Inc
13.1.1 Celldex Therapeutics Inc Company Details
13.1.2 Celldex Therapeutics Inc Business Overview
13.1.3 Celldex Therapeutics Inc Hypopharyngeal Cancer Treatment Introduction
13.1.4 Celldex Therapeutics Inc Revenue in Hypopharyngeal Cancer Treatment Business (2015-2020))
13.1.5 Celldex Therapeutics Inc Recent Development
13.2 Incyte Corp
13.2.1 Incyte Corp Company Details
13.2.2 Incyte Corp Business Overview
13.2.3 Incyte Corp Hypopharyngeal Cancer Treatment Introduction
13.2.4 Incyte Corp Revenue in Hypopharyngeal Cancer Treatment Business (2015-2020)
13.2.5 Incyte Corp Recent Development
13.3 Madrigal Pharmaceuticals Inc.
13.3.1 Madrigal Pharmaceuticals Inc. Company Details
13.3.2 Madrigal Pharmaceuticals Inc. Business Overview
13.3.3 Madrigal Pharmaceuticals Inc. Hypopharyngeal Cancer Treatment Introduction
13.3.4 Madrigal Pharmaceuticals Inc. Revenue in Hypopharyngeal Cancer Treatment Business (2015-2020)
13.3.5 Madrigal Pharmaceuticals Inc. Recent Development
13.4 Merck & Co Inc
13.4.1 Merck & Co Inc Company Details
13.4.2 Merck & Co Inc Business Overview
13.4.3 Merck & Co Inc Hypopharyngeal Cancer Treatment Introduction
13.4.4 Merck & Co Inc Revenue in Hypopharyngeal Cancer Treatment Business (2015-2020)
13.4.5 Merck & Co Inc Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Hypopharyngeal Cancer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hypopharyngeal Cancer Treatment Revenue
Table 3. Ranking of Global Top Hypopharyngeal Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hypopharyngeal Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ganetespib
Table 6. Key Players of PGV-001
Table 7. Key Players of Nimotuzumab
Table 8. Key Players of CDX-3379
Table 9. Key Players of Others
Table 10. Global Hypopharyngeal Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Hypopharyngeal Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Hypopharyngeal Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Hypopharyngeal Cancer Treatment Market Share by Regions (2015-2020)
Table 14. Global Hypopharyngeal Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Hypopharyngeal Cancer Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Hypopharyngeal Cancer Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Hypopharyngeal Cancer Treatment Players
Table 21. Global Hypopharyngeal Cancer Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Hypopharyngeal Cancer Treatment Market Share by Players (2015-2020)
Table 23. Global Top Hypopharyngeal Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypopharyngeal Cancer Treatment as of 2019)
Table 24. Global Hypopharyngeal Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Hypopharyngeal Cancer Treatment Product Solution and Service
Table 27. Date of Enter into Hypopharyngeal Cancer Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Hypopharyngeal Cancer Treatment Market Size Share by Type (2015-2020)
Table 31. Global Hypopharyngeal Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Hypopharyngeal Cancer Treatment Market Size Share by Application (2015-2020)
Table 33. Global Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Hypopharyngeal Cancer Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Hypopharyngeal Cancer Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Hypopharyngeal Cancer Treatment Market Share (2019-2020)
Table 37. North America Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Hypopharyngeal Cancer Treatment Market Share by Type (2015-2020)
Table 39. North America Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Hypopharyngeal Cancer Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Hypopharyngeal Cancer Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Hypopharyngeal Cancer Treatment Market Share (2019-2020)
Table 43. Europe Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Hypopharyngeal Cancer Treatment Market Share by Type (2015-2020)
Table 45. Europe Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Hypopharyngeal Cancer Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Hypopharyngeal Cancer Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Hypopharyngeal Cancer Treatment Market Share (2019-2020)
Table 49. China Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Hypopharyngeal Cancer Treatment Market Share by Type (2015-2020)
Table 51. China Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Hypopharyngeal Cancer Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Hypopharyngeal Cancer Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Hypopharyngeal Cancer Treatment Market Share (2019-2020)
Table 55. Japan Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Hypopharyngeal Cancer Treatment Market Share by Type (2015-2020)
Table 57. Japan Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Hypopharyngeal Cancer Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Hypopharyngeal Cancer Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Hypopharyngeal Cancer Treatment Market Share (2019-2020)
Table 61. Southeast Asia Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Hypopharyngeal Cancer Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Hypopharyngeal Cancer Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Hypopharyngeal Cancer Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Hypopharyngeal Cancer Treatment Market Share (2019-2020)
Table 67. India Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Hypopharyngeal Cancer Treatment Market Share by Type (2015-2020)
Table 69. India Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Hypopharyngeal Cancer Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Hypopharyngeal Cancer Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Hypopharyngeal Cancer Treatment Market Share (2019-2020)
Table 73. Central & South America Hypopharyngeal Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Hypopharyngeal Cancer Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Hypopharyngeal Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Hypopharyngeal Cancer Treatment Market Share by Application (2015-2020)
Table 77. Celldex Therapeutics Inc Company Details
Table 78. Celldex Therapeutics Inc Business Overview
Table 79. Celldex Therapeutics Inc Product
Table 80. Celldex Therapeutics Inc Revenue in Hypopharyngeal Cancer Treatment Business (2015-2020) (Million US$)
Table 81. Celldex Therapeutics Inc Recent Development
Table 82. Incyte Corp Company Details
Table 83. Incyte Corp Business Overview
Table 84. Incyte Corp Product
Table 85. Incyte Corp Revenue in Hypopharyngeal Cancer Treatment Business (2015-2020) (Million US$)
Table 86. Incyte Corp Recent Development
Table 87. Madrigal Pharmaceuticals Inc. Company Details
Table 88. Madrigal Pharmaceuticals Inc. Business Overview
Table 89. Madrigal Pharmaceuticals Inc. Product
Table 90. Madrigal Pharmaceuticals Inc. Revenue in Hypopharyngeal Cancer Treatment Business (2015-2020) (Million US$)
Table 91. Madrigal Pharmaceuticals Inc. Recent Development
Table 92. Merck & Co Inc Company Details
Table 93. Merck & Co Inc Business Overview
Table 94. Merck & Co Inc Product
Table 95. Merck & Co Inc Revenue in Hypopharyngeal Cancer Treatment Business (2015-2020) (Million US$)
Table 96. Merck & Co Inc Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypopharyngeal Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Ganetespib Features
Figure 3. PGV-001 Features
Figure 4. Nimotuzumab Features
Figure 5. CDX-3379 Features
Figure 6. Others Features
Figure 7. Global Hypopharyngeal Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 8. Out-Patient Case Studies
Figure 9. In-Patient Case Studies
Figure 10. Hypopharyngeal Cancer Treatment Report Years Considered
Figure 11. Global Hypopharyngeal Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Hypopharyngeal Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Hypopharyngeal Cancer Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Hypopharyngeal Cancer Treatment Market Share by Players in 2019
Figure 16. Global Top Hypopharyngeal Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypopharyngeal Cancer Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Hypopharyngeal Cancer Treatment Revenue in 2019
Figure 18. North America Hypopharyngeal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Hypopharyngeal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Hypopharyngeal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Hypopharyngeal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Hypopharyngeal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Hypopharyngeal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Hypopharyngeal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

転移性膵臓がん治療の世界市場（～2026年）

Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12667 2020年11月25日 99Pages
当調査資料は転移性膵臓がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、標的療法、その他）市場規模、用途別（外分泌、内分泌）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台...

甲状腺がん治療の世界市場（～2026年）

Global Thyroid Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04851 2020年11月20日 92Pages
当調査資料は甲状腺がん治療のグローバル市場について調査・分析したレポートです。種類別（手術、ヨウ素療法、体外照射療法、サイロキシン治療、化学療法、薬物）市場規模、用途別（病院、腫瘍学センター、病院薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...

非血液がん治療の世界市場（～2026年）

Global Non-Hematological Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04000 2020年11月20日 97Pages
当調査資料は非血液がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、手術、放射線療法、その他）市場規模、用途別（病院、腫瘍治療センター、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

前立腺がん治療の世界市場（～2026年）

Global Prostate Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04391 2020年11月20日 91Pages
当調査資料は前立腺がん治療のグローバル市場について調査・分析したレポートです。種類別（生物学的療法、化学療法）市場規模、用途別（病院、研究機関、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア...

小細胞肺がん治療の世界市場（～2026年）

Global Small Cell Lung Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04652 2020年11月20日 99Pages
当調査資料は小細胞肺がん治療のグローバル市場について調査・分析したレポートです。種類別（小細胞がん、混合型小細胞がん）市場規模、用途別（手術、放射線療法、化学療法）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...

転移性がん治療の世界市場（～2026年）

Global Metastatic Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12665 2020年11月25日 91Pages
当調査資料は転移性がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

トリプルネガティブ乳がん治療の世界市場（～2026年）

Global Triple-Negative Breast Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04900 2020年11月20日 90Pages
当調査資料はトリプルネガティブ乳がん治療のグローバル市場について調査・分析したレポートです。種類別（アルキル化剤、植物製品、微生物製品、代謝拮抗剤、微小管安定剤）市場規模、用途別（病院薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

HER2陰性乳がん治療の世界市場（～2026年）

Global HER2-negative breast cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12176 2020年11月25日 97Pages
当調査資料はHER2陰性乳がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、手術、放射線、ホルモン療法/内分泌療法）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国...

口腔がん治療の世界市場（～2026年）

Global Oral Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04078 2020年11月20日 98Pages
当調査資料は口腔がん治療のグローバル市場について調査・分析したレポートです。種類別（扁平上皮がん、疣贅がん、小唾液腺がん、リンパ腫）市場規模、用途別（病院・診療所、研究機関、学術機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...

去勢抵抗性前立腺がん治療の世界市場（～2026年）

Global Castration Resistant Prostate Cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11289 2020年11月25日 97Pages
当調査資料は去勢抵抗性前立腺がん治療のグローバル市場について調査・分析したレポートです。種類別（ホルモン療法、抗アンドロゲン追加、抗アンドロゲン中止、エストロゲン、化学療法、放射線療法、その他）市場規模、用途別（病院、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラン...

転移性膵臓がん治療の世界市場（～2026年） Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metasta…
甲状腺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Thyroid Cancer Treatment Market The global Thyroid Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Thyroid Cancer Treatment Scope and Market Size Thyroid Cancer Tre…
非血液がん治療の世界市場（～2026年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…
小細胞肺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small Cell Lung Cancer Treatment Scope and Market…
前立腺がん治療の世界市場（～2026年） Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race. Market Analysis and Insights: Global Prostate Cancer Treatment Market The global Prostate Cancer Treatment market size is projected to reach US$ XX m…